Front Row Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15
Closed -$1.29K 612
2024
Q2
$1.29K Hold
15
﹤0.01% 881
2024
Q1
$1.24K Buy
+15
New +$1.1K ﹤0.01% 870
2023
Q4
Sell
-15
Closed -$1.01K 580
2023
Q3
$1.01K Hold
15
﹤0.01% 867
2023
Q2
$1K Hold
15
﹤0.01% 850
2023
Q1
$1K Hold
15
﹤0.01% 866
2022
Q4
$1K Hold
15
﹤0.01% 837
2022
Q3
$1K Sell
15
-4
-21% -$200 ﹤0.01% 869
2022
Q2
$1K Hold
19
﹤0.01% 878
2022
Q1
$1K Hold
19
﹤0.01% 896
2021
Q4
$1K Hold
19
﹤0.01% 908
2021
Q3
$1K Hold
19
﹤0.01% 905
2021
Q2
$1K Hold
19
﹤0.01% 909
2021
Q1
$1K Hold
19
﹤0.01% 907
2020
Q4
$1K Hold
19
﹤0.01% 871
2020
Q3
$1K Hold
19
﹤0.01% 871
2020
Q2
$1K Hold
19
﹤0.01% 921
2020
Q1
$1K Hold
19
﹤0.01% 894
2019
Q4
$1K Hold
19
﹤0.01% 849
2019
Q3
$1K Hold
19
﹤0.01% 859
2019
Q2
$1K Hold
19
﹤0.01% 947
2019
Q1
$1K Hold
19
﹤0.01% 948
2018
Q4
$1K Hold
19
﹤0.01% 926
2018
Q3
$1K Hold
19
﹤0.01% 893
2018
Q2
$1K Hold
19
﹤0.01% 937
2018
Q1
$1K Hold
19
﹤0.01% 869
2017
Q4
$1K Buy
+19
New +$723 ﹤0.01% 762

Other funds holding EHC

Front Row Advisors's EHC Position: Q3 2024 in Review

Front Row Advisors sold out of Encompass Health (EHC) in Q3 2024, closing a stake of 15 shares — an estimated $1.29K sold.

Front Row Advisors first reported a position in EHC in Q4 2017 and held it in 26 quarters. The position peaked at $1.29K in Q2 2024. 482 funds tracked by Wall St. Rank hold EHC as of Q3 2024.

  • Front Row Advisors reported no remaining Encompass Health position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 15 Encompass Health shares in Q3 2024, an estimated $1.29K.
  • Front Row Advisors first reported a position in Encompass Health in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Encompass Health position peaked at $1.29K in Q2 2024.
  • 482 funds tracked by Wall St. Rank held Encompass Health as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.